Holen Sie sich die Stockscreener-App
127.34
3.88%
4.76
Handel nachbörslich:
127.49
0.15
+0.12%
Finanzdaten der Palvella Therapeutics Inc-Aktie (PVLA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
44.09%
21.41
|
14.86 | 11.30 | 10.18 | 9.25 |
| Operating Income/Loss |
44.09%
-21.41
|
-14.86 | -11.30 | -10.18 | -9.25 |
| Net Interest Income/Expense |
83.13%
1.965
|
1.073 | 0.52 | 0.628 | 0.69 |
| Income/Loss From Continuing Operations Before Tax |
38.71%
-21.87
|
-15.77 | -12.71 | -11.35 | -9.471 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
38.71%
-21.87
|
-15.77 | -12.71 | -11.35 | -9.471 |
| Basic Average Shares |
9.71%
14.36
|
13.09 | - | 11.06 | 11.05 |
| Diluted Average Shares |
9.71%
14.36
|
13.09 | - | 11.06 | 11.05 |
| Basic Earnings Per Share |
26.67%
-1.52
|
-1.20 | - | -1.03 | -0.86 |
| Diluted Earnings Per Share |
26.67%
-1.52
|
-1.20 | - | -1.03 | -0.86 |
3.96%
0.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):